At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 48 enrolled
Drug / intervention
Warfarin +2 moredrug
Likely dose
Warfarin 5mg + Rosuvastatin 40 mg once daily (QD)from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers
In Brief
A Phase 4 clinical trial evaluating Warfarin, Warfarin 5mg + Rosuvastatin 40 mg once daily (QD), and 1 other intervention for Healthy. Completed, enrolled 48 participants across 1 site.
Detailed Summary
This is a Phase 4, single center, open label, 4 period, 2 treatment, crossover, drug-drug interaction study.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2010
First PostedAug 2010
Primary CompletionOct 2010
Study CompletionApr 2011
TodayJul 2026
First PostedAug 10, 2010
Enrollment StartJul 1, 2010
Primary CompletionOct 1, 2010
Study CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 15.9 years ago
Interventions
Warfarindrug
Warfarin 5 mg once daily
Warfarin 5mg + Rosuvastatin 40 mg once daily (QD)drug
Warfarin 5mg + Rosuvastatin 40 mg once daily (QD)
Warfarin 5 mg + Pitavastatin 4mg once daily (QD)drug
Warfarin 5 mg + Pitavastatin 4mg